<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01580566</url>
  </required_header>
  <id_info>
    <org_study_id>CP-03/11</org_study_id>
    <nct_id>NCT01580566</nct_id>
  </id_info>
  <brief_title>Renal Acute MI Study</brief_title>
  <official_title>Renal Structural, Functional and Cytokine Responses to Acute Myocardial Injury in Man</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Monash University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Monash University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if a sizable myocardial infarction (heart attack)
      results in negative changes to renal structure and function (i.e. has a negative impact on
      the kidneys).

      To determine if the renal response to a myocardial infarction is a predictor of the patients
      future health.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic heart and kidney disease are increasingly common in Western society. Both conditions
      are associated with frequent hospitalisation and increased mortality. Furthermore, there are
      mechanistic reasons why one condition may beget the other; the so-called &quot;cardiorenal
      syndrome&quot;. The investigators therefore wish to determine if a sizable myocardial infarction
      (heart attack) results in negative changes to renal structure and function (i.e. has a
      negative impact on the kidneys). The investigators also wish to determine if the renal
      response to a myocardial infarction is a predictor of the patients future health. To do this
      the investigators will measure markers of kidney function at the time of the heart attach, at
      discharge, 1 month, 6 months and 12 months and correlate this with the patients clinical
      condition.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>changes in renal function and structure</measure>
    <time_frame>Baseline, discharge, 1 month, 6 months and 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>renal response to myocardial infarction</measure>
    <time_frame>baseline, discharge, 1 month, 6 months and 12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>Kidney Function</condition>
  <arm_group>
    <arm_group_label>Group 1 - Control</arm_group_label>
    <description>Non-Q wave MI subjects with normal cardiac and renal function (defined as eGFR &gt;60ml/min) not undergoing a cardiac procedure involving contrast will serve as &quot;control&quot; for renal injury subjects.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2 - stable CAD or non-Q wave MI</arm_group_label>
    <description>Patients undergoing coronary angiography +/- PCI for stable CAD or non-Q wave MI with normal cardiac and renal function (defined as eGFR &gt;60ml/min) will control for the contrast STEMI patients are likely to receive as part of their post-MI management</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3 - Acute STEMI without chronic kidney disease</arm_group_label>
    <description>Acute STEMI patients (n=40), without chronic kidney disease (defined as eGFR ≥60ml/min).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4 - Acute STEMI with kidney disease</arm_group_label>
    <description>Acute STEMI patients (n=40), with evidence of background chronic kidney disease (eGFR &lt;60ml/min).</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples to measure bio-markers
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who have presented to the Emergency Department with chest pain caused by a
        possible myocardial infarction.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Age &gt; 18 years

        Have provided written informed consent

        Group 1:

          -  Non-Q wave MI patients

          -  normal cardiac and renal function

          -  No use of contrast

          -  eGFR &gt; 60ml/min

        Group 2:

          -  Patients undergoing coronary angiography +/- PCI for stable CAD or non-Q wave MI

          -  normal cardiac and renal function

          -  eGFR &gt; 60ml/min

        Group 3:

          -  Acute STEMI Full thickness infarct (STEMI)

          -  eGFR ≥ 60ml/min

        Group 4:

          -  Acute STEMI Full thickness infarct (STEMI)

          -  eGFR &lt; 60ml/min

        Exclusion Criteria:

          -  Unable or unwilling to comply with the study protocol

          -  Underlying medical condition which, in the opinion of the investigator, will effect
             the safely or efficacy of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henry Krum, MBBS FRACP PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alfred Hospital/Monash.University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Henry Krum, MBBS FRACP PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alfred Hospital/Monash University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Henry Krum, MBBS FRACP PhD</last_name>
    <phone>+613 9903 0042</phone>
    <email>henry.krum@monash.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Alfred Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henry Krum, MBBS FRACP PhD</last_name>
      <phone>+613 9903 0042</phone>
      <email>henry.krum@monash.edu</email>
    </contact>
    <investigator>
      <last_name>Henry Krum, MBBS FRACP PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2012</study_first_submitted>
  <study_first_submitted_qc>April 18, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 19, 2012</study_first_posted>
  <last_update_submitted>April 9, 2017</last_update_submitted>
  <last_update_submitted_qc>April 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Monash University</investigator_affiliation>
    <investigator_full_name>Ingrid Hopper</investigator_full_name>
    <investigator_title>Seniour Lecturer</investigator_title>
  </responsible_party>
  <keyword>Myocardial Infarction (MI)</keyword>
  <keyword>Kidney function</keyword>
  <keyword>bio-markers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

